Nordic Life Science 1
When I left the CHMP nine years ago I wanted to f
ind a place where I could put the knowledge gained working as a regulator to good use. I wanted the opportunity to work with a broad range of products and regulatory and scientific challenges. NDA is a special kind of regulatory service provider. Firstly, the level of experience in the team is outstanding. Many colleagues are ex regulators who have been sitting on the other side of the desk and who have experienced the expectations of the regulatory authorities first hand. Secondly, the firm belief in the value of providing unbiased advice. Getting unbiased advice is paramount to your drug development process. We believe that telling you what you need to hear, rather than only what you want to hear, is the greatest opportunity for you to accelerate your drug development process and ensure that patients get access to good, safe medicines. If unmatched expertise and unbiased advice to help you drive excellent outcomes are what you are looking for, then you should talk to us. Let’s bring medicines to the world. Because the world is waiting. www.ndareg.com Steffen Thirstrup, Director NDA Advisory Board